Kate Gelperin, MD, MPH

Medical Officer
US Food and Drug Administration

Poster(s):

• (234) Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (235) Analysis of Postapproval Pregnancy Safety Studies Associated with FDA Approved Products
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (312) Sources and Characteristics of Quantitative Human Pregnancy Safety Data in U.S. FDA Approved Product Labeling, 2015-2021
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST